Data is not available at this time.
Atomera Incorporated operates in the semiconductor industry, specializing in advanced materials science to enhance transistor performance. The company's core revenue model is built on licensing its proprietary MST® (Mears Silicon Technology) to semiconductor manufacturers, enabling improved power efficiency and performance in integrated circuits. Atomera does not fabricate chips but instead provides a scalable, IP-driven solution that integrates seamlessly into existing manufacturing processes, targeting foundries and IDMs (Integrated Device Manufacturers). The semiconductor sector is highly competitive, with Atomera positioning itself as a technology enabler rather than a direct competitor to chipmakers. Its MST® technology addresses critical industry challenges such as power consumption and heat dissipation, which are pivotal for next-generation devices in AI, IoT, and 5G applications. While the company holds a niche position, its success hinges on widespread adoption by major semiconductor players, which remains a work in progress given the industry's cautious adoption cycles and high R&D barriers.
Atomera reported modest revenue of $135,000 for FY 2024, reflecting its early-stage licensing focus. The company posted a net loss of $18.4 million, with diluted EPS of -$0.68, underscoring its pre-commercialization phase. Operating cash flow was negative at $13.2 million, with no capital expenditures, indicating heavy investment in R&D and business development rather than physical assets.
The company's earnings power remains constrained due to limited licensing agreements and high operating expenses. With no significant recurring revenue streams, Atomera's capital efficiency is currently low, as evidenced by its negative operating cash flow. The focus remains on scaling MST® adoption, which could improve margins if licensing gains traction with major semiconductor manufacturers.
Atomera maintains a solid liquidity position with $25.8 million in cash and equivalents, providing a runway for continued operations. Total debt is minimal at $1.98 million, resulting in a strong net cash position. The absence of dividends aligns with its growth-focused strategy, prioritizing reinvestment over shareholder payouts.
Growth is contingent on broader adoption of MST® technology, which has yet to achieve commercial scale. The company does not pay dividends, reflecting its focus on reinvesting capital into R&D and market penetration. Future trends will depend on securing additional licensing deals and demonstrating the technology's value in high-volume production environments.
The market likely values Atomera based on its long-term potential rather than current financials, given its pre-revenue status in a high-growth industry. Investors appear to be betting on the eventual widespread adoption of MST®, though the timeline remains uncertain. The lack of profitability and reliance on licensing deals introduce significant volatility to its valuation.
Atomera's key advantage lies in its proprietary MST® technology, which addresses critical semiconductor performance challenges. However, the outlook is speculative, hinging on adoption by major industry players. Success would position the company as a key enabler of next-generation chips, but execution risks and competitive pressures remain high. Near-term focus will likely remain on partnerships and proving the technology's scalability.
Company filings (10-K), investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |